Authors


Shu-Min Mai, MS

Latest:

Patient Value Co-creation Behavior Scale Based on the DART Model

This study aimed to develop and evaluate the psychometric properties of a scale measuring patient value co-creation behavior based on the DART (Dialogue, Access, Risk assessment, Transparency) model.


Francesco Sparano, MSc | Image Credit: LinkedIn
Francesco Sparano, MSc

Latest:

Quality of Life Disparities Persist in R/R Multiple Myeloma Despite Universal Health Care: Francesco Sparano, MSc

Patients with relapsed/refractory myeloma from lower socioeconomic groups face worse quality of life, even in countries with universal health care, according to Francesco Sparano, MSc, of the Italian-based GIMEMA Foundation.


Katia L. Hannah, PhD, MPH

Latest:

Combined Effect of Continuous Glucose Monitoring and Semaglutide: Analysis of Administrative Claims

Claims data reveal larger hemoglobin A1c decreases in people with type 2 diabetes who use continuous glucose monitoring and semaglutide compared with semaglutide alone.


Valerie A. Yeager, DrPH, MPhil

Latest:

Primary Care Case Conferences to Mitigate Social Determinants of Health: A Case Study From One FQHC System

This article describes perceived benefits, facilitators, and challenges of conducting interprofessional team case conferences in primary care settings to address patients’ complex social needs.


Richard Young, MS

Latest:

Unfulfilled Home Health Referrals Lead to Higher Mortality Among Medicare Advantage Members

Medicare Advantage members referred to home health after acute hospitalization who did not receive home health services had higher mortality at 30, 90, and 180 days.



Tara Graff, DO

Latest:

Future Directions and Research Priorities in BTKi Treatment Approaches

Panelists discuss how challenges in implementing emerging Bruton tyrosine kinase inhibitor (BTKi) regimens for treatment-naive patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) may include issues related to access, cost, and patient adherence, and highlight the need for ongoing research and collaboration to optimize BTKi use and improve patient outcomes in both diseases.


Jim Kinville

Latest:

Mental Health Awareness: Transforming Workplace Support and Engagement

Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.


Jeffrey Dunn, PharmD, MBA

Latest:

Stakeholder Insights on rtCGM in T2D Population Health Management

Leading payer and health system stakeholders reviewed literature and shared insights on the value of real-time continuous glucose monitoring (rtCGM) in type 2 diabetes (T2D) population health.


Abaki Beck, MPH

Latest:

Predictors of and Barriers to Receipt of Advance Premium Tax Credits

Few eligible individuals apply for the Advance Premium Tax Credit due to knowledge barriers. Additionally, specific sociodemographic characteristics appear to predict applying status.


Zeel Shah, MD

Latest:

Medical Home Visit Programs During COVID-19 State of Emergency

This report highlights the unique challenges faced by home health programs in addition to discussing how technology and policy changes have helped the elderly homebound during the coronavirus disease 2019 (COVID-19) pandemic.


Lori Hartwell, CEO, Renal Support Network
Lori Hartwell

Latest:

Contributor: Medicare Policy Proposal Jeopardizes Care for Those on Dialysis

CEOs of 3 kidney care organizations explain flaws in CMS' recent reimbursement proposal.


Aig Unuigbe, PhD

Latest:

High-Need Beneficiary Enrollment Patterns in Medicare Advantage and Traditional Medicare

Accounting for 32% of all Medicare enrollees in 2019, high-need beneficiaries were more likely to be in traditional Medicare than Medicare Advantage.


Sarah K. Dutcher, PhD

Latest:

Preferences for and Experiences With Pill Appearance Changes: National Surveys of Patients and Pharmacists

Changes in generic drug appearance occur often. Patients’ and pharmacists’ responses to those changes vary, with some patients stopping their medication or using it less.


Steven Daniel Daveluy, MD, FAAD

Latest:

Balancing Efficacy, Safety, and Lifestyle in Psoriasis Therapy: Steven Daveluy, MD

Shared decision-making helps dermatologists align treatment plans with patient needs, improving adherence and outcomes.


Edward C. Norton, PhD

Latest:

Hospital Performance in a Statewide Commercial Insurer Episode-Based Incentive Program

Some hospitals were able to outperform others in a commercial insurer episode-based incentive program, but there was little evidence of global reductions in episode spending.


Lisa Young, MSc

Latest:

Bleeds and Resource Use in Hemophilia B: Retrospective Observational Study

This real-world US study describes individuals with hemophilia B who experience bleeds despite factor replacement therapy and quantifies the associated comorbidity and health care resource utilization burden.


Bruce Dorr, MD, FPMRS, FACOG
Bruce Dorr, MD, FPMRS, FACOG

Latest:

Contributor: In the Misdiagnosis of Menopause, What Needs to Change?

Menopause symptoms are not being recognized, leading to misdiagnosis and improper treatment.


Patrick J. Campbell, PharmD, PhD

Latest:

COPD Treatment Ratio: A Measure for Improving COPD Population Health

This article supports the use of the chronic obstructive pulmonary disease (COPD) treatment ratio as a surrogate marker of COPD exacerbation risk for quality measurement purposes.


Scott Mandel, MD

Latest:

Long-Term Consequences of Arrhythmias

Experts discuss the complex clinical and economic challenges of atrial fibrillation, emphasizing the need for personalized care that balances symptom management, stroke prevention, and risk factor control—while recent evidence on subclinical atrial fibrillation highlights the limitations of widespread anticoagulation, reinforcing the importance of targeted, value-based strategies for optimal outcomes.



Christine E. Chaisson, MPH

Latest:

Teamwork Enhances Patient Experience: Linking TEAM and Net Promoter Scores

In 1386 providers, better teamwork related to higher patient Net Promoter Score (NPS), and the relationship between provider experience and NPS was mediated by teamwork.


Aaron Farberg, MD

Latest:

Switching to Biosimilars for the Management of Psoriasis

An expert discusses how examining biosimilars in trials ensures safety, efficacy, and interchangeability, key for clinical adoption. The phase 3 study’s week 52 results confirmed consistent pharmacokinetics, efficacy, and safety. As confidence grows, biosimilars will expand treatment access for psoriasis patients.


Dr Lillian L. Siu | Image Credit: AACR
Lillian L. Siu, MD, FAACR

Latest:

Breaking Barriers, Fostering Collaboration at AACR Annual Meeting 2025

Program chairs Lillian L. Siu, MD, FAACR, and Matthew G. Vander Heiden, MD, PhD, highlight the cross-disciplinary approach to cancer research and innovation being taken at this year's American Association for Cancer Research (AACR) Annual Meeting.


Kathleen Y. Li, MD, MSc

Latest:

Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending

Hospital accountable care organization (ACO) participation did not impact emergency department admission rates, length of stay, or costs, suggesting limited effectiveness in reducing spending for unplanned admissions and challenging hospital-led ACO cost-saving strategies.


Louis D. Falo Jr, MD, PhD

Latest:

Access to Consultative Dermatologic Care via Physician-to-Physician Asynchronous Outpatient Teledermatology

Direct access of primary care physicians to dermatologists via asynchronous teledermatology improves a health system’s ability to increase patient access to dermatologic care.


Mehmet Oz, MD, MBA

Latest:

AI Is Not Going to Replace Doctors, It’s Going to Empower Them: Dr Mehmet Oz

During a visit to AtlantiCare, CMS Administrator Mehmet Oz, MD, MBA, called for rural health systems to modernize IT infrastructure through the $50 billion Rural Transformation Fund, including through artificial intelligence (AI).



Toby Maher, MD, PhD

Latest:

FIBRONEER Trials Show Nerandomilast's Promise as New Treatment Option for IPF/PPF: Toby Maher, MD, PhD

Toby Maher, MD, PhD, professor of clinical medicine, Keck School of Medicine at USC, shares trial findings from the FIBRONEER-IPF (NCT05321069) and FIBRONEER-ILD (NCT05321082) studies on nerandomilast.


Jürgen Unützer, MD, MPH, MA

Latest:

Effective Implementation of Collaborative Care for Depression: What Is Needed?

Factors most important for successful implementation of collaborative care for depression differ for patient activation versus achieving remission; both are critical to program success.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo